Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 187

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Lipids and lipidomics in brain injury and diseases

Open access
Adibhatla, Rao Muralikrishna, Hatcher, J. F., Dempsey, R. J. · 2006 · The AAPS Journal

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/bf02854902

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 70

  1. Piomelli D. The challenge of brain lipidomics.Prostaglandins Other Lipid Mediat. 2003;77:23–34. · DOI
  2. Fahy E, Subramaniam S, Brown HA, et al. A comprehensive classification system for lipids.J Lipid Res. 2005;46:839–862. · DOI · Paper page
  3. Wenk MR. The emerging field of lipidomics.Nat Rev Drug Discov. 2005;4:594–610. · DOI · Paper page
  4. Hannun YA, Luberto C, Argraves KM. Enzymes of sphingolipid metabolism: from modular to integrative signaling.Biochemistry. 2001;40:4893–4903. · DOI · Paper page
  5. Peterson BL, Cummings BS. A review of chromatographic methods for the assessment of phospholipids in biological samples.Biomed Chromatogr. 2006;20:227–243. · DOI · Paper page
  6. Balazy M. Eicosanomics: targeted lipidomics of eicosanoids in biological systems.Prostaglandins Other Lipid Mediat. 2004;73:173–180. · DOI
  7. Hillard CJ. Lipids and drugs of abuse.Life Sci. 2005;77:1531–1542. · DOI
  8. van Meer G. Cellular lipidomics.EMBO J. 2005;24:3159–3165. · DOI · Paper page
  9. Rapaka RS, Piomelli D, Spiegel S, Bazan N, Dennis EA. Targeted lipidomics: signaling lipids and drugs of abuse.Prostaglandins Other Lipid Mediat. 2005;77:223–234. · doi:10.1016/j.prostaglandins.2005.06.005
  10. Belayev L, Marcheselli VL, Khoutorova L, et al. Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection.Stroke. 2005;36:118–123. · DOI
  11. Forrester JS, Milne SB, Ivanova PT, Brown HA. Computational lipidomics: a multiplexed analysis of dynamic changes in membrane lipid composition during signal transduction.Mol Pharmacol. 2004;65:813–821. · DOI
  12. Han X, Yang J, Cheng H, Yang K, Abendschein DR, Gross RW. Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction.Biochemistry. 2005;44:16684–16694. · DOI · Paper page
  13. Hunt AN, Fenn HC, Clark GT, Wright MM, Postle AD, McMaster CR. Lipidomic analysis of the molecular specificity of a cholinephosphotransferase in situ.Biochem Soc Trans. 2004;32:1060–1062. · DOI
  14. Brugger B, Erben G, Sandhoff R, Wieland FT, Lehmann WD. Quantitative analysis of biological membrane lipids at the low picomole level by nano-electrospray ionization tandem mass spectrometry.Proc Natl Acad Sci USA. 1997;94:2339–2344. · DOI · Paper page
  15. Pulfer M, Murphy RC. Electrospray mass spectrometry of phospholipids.Mass Spectrom Rev. 2003:22:332–364. · DOI · Paper page
  16. Schiller J, Suss R, Arnhold J, et al. Matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF) mass spectrometry in lipid and phospholipid research.Prog Lipid Res. 2004;43:449–488. · DOI · Paper page
  17. Fisher M, Brott TG. Emerging therapies for acute ischemic stroke: new therapies on trial.Stroke. 2003;34:359–361. · DOI
  18. Siao CJ, Fernandez SR, Tsirka SE. Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury.J Neurosci. 2003;23:3234–3242. · DOI
  19. Adibhatla RM, Hatcher JF, Dempsey RJ. Effects of citicoline on phospholipid and glutathione levels in transient cerebral ischemia.Stroke. 2001;32:2376–2381. · DOI
  20. Adibhatla RM, Hatcher JF, Dempsey RJ. Phospholipase A2, hydroxyl radicals and lipid peroxidation in transient cerebral ischemia.Antioxid Redox Signal. 2003;5:647–654. · DOI
  21. Adibhatla RM, Hatcher JF. Citicoline decreases phospholipase A2 stimulation and hydroxyl radical generation in transient cerebral ischemia.J Neurosci Res. 2003;73:308–315. · DOI
  22. Muralikrishna Adibhatla R, Hatcher JF. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia.Free Radic Biol Med. 2006;40:376–387. · DOI · Paper page
  23. Adibhatla RM, Hatcher JF, Larsen EC, Chen X, Sun D, Tsao FH. CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP-phosphocholine cytidylyltransferase after stroke.J Biol Chem. 2006;281:6718–6725. · DOI
  24. Rao AM, Hatcher JF, Kindy MS, Dempsey RJ. Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils.Neurochem Res. 1999;24:1225–1232. · DOI
  25. Rao AM, Hatcher JF, Dempsey RJ. CDP-choline: neuroprotection in transient forebrain ischemia of gerbils.J Neurosci Res. 1999;58:697–705. · doi:10.1002/(sici)1097-4547(19991201)58:5<697::aid-jnr11>3.0.co;2-b
  26. Rao AM, Hatcher JF, Dempsey RJ. Lipid metabolism in ischemic neuronal death.Recent Res Develop Neurochem. 1999;2:533–549.
  27. Rao AM, Hatcher JF, Dempsey RJ. Lipid alterations in transient forebrain ischemia: possible new mechanisms of CDP-choline neuroprotection.J Neurochem. 2000;75:2528–2535. · DOI
  28. Rao AM, Hatcher JF, Dempsey RJ. Does CDP-choline modulate phospholipase activities after transient forebrain ischemia?Brain Res. 2001;893:268–272. · DOI
  29. Sastry PS, Rao KS. A poptosis and the nervous system.J Neurochem. 2000;74:1–20. · DOI · Paper page
  30. Adibhatla RM, Hatcher JF. Cytidine 5′-diphosphocholine (CDP-choline) in stroke and other CNS disorders.Neurochem Res. 2005;30:15–23. · DOI · Paper page
  31. Ter Horst GJ, Korf J, eds.Clinical Pharmacology of Cerebral Ischemia. Totowa, NJ: Humana, 1997.
  32. Choi DW. Methods for antagonizing glutamate neurotoxicity.Cerebrovasc Brain Metab Rev. 1990;2:105–147.
  33. Bazan NG. Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress.Brain Pathol. 2005;15:159–166. · DOI · Paper page
  34. Bazan NG, Marcheselli VL, Cole-Edwards K. Brain response to injury and neurodegeneration: endogenous neuroprotective signaling.Ann NY Acad Sci. 2005;1053:137–147. · DOI
  35. Lukiw WJ, Cui J-G, Marcheselli VL, et al. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease.J Clin Invest. 2005;115;2774–2783. · DOI · Paper page
  36. Cui Z, Houweling M. Phosphatidylcholine and cell death.Biochim Biophys Acta. 2002;1585:87–96. · DOI · Paper page
  37. Freeman EJ, Terrian DM, Dorman RV. Presynaptic facilitation of glutamate release from isolated hippocampal mossy fiber nerve endings by arachidonic acid.Neurochem Res. 1990;15:743–750. · DOI
  38. Ruehr ML, Zhang L, Dorman RV. Lipid-dependent modulation of Ca2+ availability in isolated mossy fiber nerve endings.Neurochem Res. 1997;22:1215–1222. · DOI
  39. Jayadev S, Linardic CM, Hannun YA. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to TNF-α.J Biol Chem. 1994;269:5757–5763. · DOI · Paper page
  40. Hannun YA, Obeid LM. Ceramide: an intracellular signal for apoptosis.Trends Biochem Sci. 1995;20:73–77. · DOI · Paper page
  41. Green DR, Reed JC. Mitochondria and apoptosis.Science. 1998;281:1309–1312. · DOI · Paper page
  42. Perry DK, Hannun YA. The role of ceramide in cell signaling.Biochim Biophys Acta. 1998;1436:233–243. · DOI · Paper page
  43. Kinloch RA, Treherne JM, Furness LM, Hajimohamadreza I. The pharmacology of apoptosis.Trends Pharmacol Sci. 1999;20:35–42. · DOI
  44. Goswami R, Dawson G. Does ceramide play a role in neural cell apoptosis?J Neurosci Res. 2000;60:141–149. · doi:10.1002/(sici)1097-4547(20000415)60:2<141::aid-jnr2>3.0.co;2-5
  45. Garcia-Ruiz C, Colell A, Mari M, Morales A, Fernandezcheca JC. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species—role of mitochondrial glutathione.J Biol Chem. 1997;272:11369–11377. · DOI · Paper page
  46. Ghafourifar P, Klein SD, Schucht O, et al. Ceramide induces cytochrome c release from isolated mitochondria. Importance of mitochondrial redox state.J Biol Chem. 1999;274:6080–6084. · DOI · Paper page
  47. Cai J, Yang J, Jones DP. Mitochondrial control of apoptosis—the role of cytochrome c.Biochim Biophys Acta. 1998;1366:139–149. · DOI · Paper page
  48. Hoch FL. Cardiolipins and biomembrane function.Biochim Biophys Acta. 1992;1113:71–133. · DOI · Paper page
  49. Nakahara I, Kikuchi H, Taki W, et al. Degradation of mitochondrial phospholipids during experimental cerebral ischemia in rats.J Neurochem. 1991;57:839–844. · doi:10.1111/j.1471-4159.1991.tb08227.x
  50. Nakahara I, Kikuchi H, Taki W, et al. Changes in major phospholipids of mitochondria during postischemic reperfusion in rat brain.J Neurosurg. 1992;76:244–250. · DOI
  51. Rimon G, Bazenet CE, Philpott KL, Rubin LL. Increased surface phosphatidylserine is an early marker of neuronal apoptosis.J Neurosci Res. 1997;48:563–570. · doi:10.1002/(sici)1097-4547(19970615)48:6<563::aid-jnr9>3.0.co;2-8
  52. Suzuki S, Furushiro M, Takahashi M, Sakai M, Kudo S. Oral administration of soybean lecithin transphosphatidylated phosphatidylserine (SB-tPS) reduces ischemic damage in the gerbil hippocampus.Jpn J Pharmacol. 1999;81:237–239. · doi:10.1254/jjp.81.237
  53. Katsuki H, Okuda S. Arachidonic acid as a neurotoxic and neurotrophic substance.Prog Neurobiol., 1995;46:607–636. · DOI · Paper page
  54. Kruman I, Brucekeller AJ, Bredesen D, Waeg G, Mattson MP. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis.J Neurosci. 1997;17:5089–5100. · DOI · Paper page
  55. Uchida K, Kanematsu M, Sakai K, et al. Protein-bound acrolein—potential markers for oxidative stress.Proc Natl Acad Sci USA. 1998;95:4882–4887. · DOI · Paper page
  56. Calingasan NY, Uchida K, Gibson GE. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.J Neurochem. 1999;72:751–756. · DOI · Paper page
  57. Adibhatla RM, Hatcher JF. Citicoline mechanisms and clinical efficacy in cerebral ischemia.J Neurosci Res. 2002;70:133–139. · DOI
  58. Adibhatla RM, Hatcher JF, Dempsey RJ. Cytidine-5′-diphosphocholine (CDP-choline) affects CTP-phosphocholine cytidylyltransferase and lyso-phosphatidylcholine after transient brain ischemia.J Neurosci Res. 2004;76:390–396. · DOI
  59. Kudo I. Diversity of phospholipase A2 enzymes. Foreword.Biol. Pharm Bull. 2004;27:1157. · doi:10.1248/bpb.27.1157
  60. Williams TI, Lynn BC, Markesbery WR, Lovell MA. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease.Neurobiol Aging. In press. · DOI · Paper page
  61. Urabe T, Hattori N, Yoshikawa M, Yoshino H, Uchida K, Mizuno Y. Colocalization of Bcl-2 and 4-hydroxynomenal modified proteins in microglial cells and neurons of rat brain following transient focal ischemia.Neurosci Lett. 1998;247:159–162. · DOI
  62. Urabe T, Yamasaki Y, Hattori N, Yoshikawa M, Uchida K, Mizuno Y. Accumulation of 4-hydroxynonenal-modified proteins in hippocampal CA1 pyramidal neurons precedes delayed neuronal damage in the gerbil brain.Neuroscience. 2000;100:241–250. · DOI
  63. Uchida K, Kanematsu M, Morimitsu Y, Osawa T, Noguchi N, Niki E. Acrolein is a product of lipid peroxidation reaction—formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins.J Biol Chem. 1998;273:16058–16066. · DOI · Paper page
  64. Tomitori H, Usui T, Saeki N, et al. Polyamine oxidase and acrolein as novel biochemical markers for diagnosis of cerebral stroke.Stroke. 2005;36:2609–2613. · DOI · Paper page
  65. Liu X, Lovell MA, Lynn BC. Development of a method for quantification of acrolein-deoxyguanosine adducts in DNA using isotope dilution-capillary LC/MS/MS and its application to human brain tissue.Anal Chem. 2005;77:5982–5989. · DOI
  66. Cejka D, Losert D, Wacheck V. Short interfering RNA (siRNA): tool or therapeutic?Clin Sci (Lond). 2006;110:47–58. · DOI
  67. Dykxhoorn DM, Palliser D, Lieberman J. The silent treatment siRNAs as small molecule drugs.Gene Ther. 2006;13:541–552. · DOI · Paper page
  68. Wang L, Magdaleno S, Tabas I, Jackowski S. Early embryonic lethality in mice with targeted deletion of the CTP:phosphocholine cytidylyltransferase alpha gene (Pcytla).Mol Cell Biol. 2005;25:3357–3363. · DOI
  69. Klein J. Functions and pathophysiological roles of phospholipase D in the brain.J Neurochem. 2005;94:1473–1487. · DOI
  70. Pettus BJ, Bielawski J, Porcelli AM, et al. The sphingosine kinase 1/sphingosine-1-phosphate pathway mediates COX-2 induction and PGE2 production in response to TNF-α.FASEB J. 2003;17:1411–1421. · DOI · Paper page

Cited by

See all 187

Metadata

Authors
Adibhatla, R. M., Hatcher, J. F., & Dempsey, R. J.
Venue
The AAPS Journal
Published
2006-06
Volume
8
Issue
2
Pages
E314-E321
ISSN
1550-7416 (ISSN-L)
OpenAlex
W2081808464
Cited by
187
References
6
FWCI
4.42
Type
journal article
Language
en
Open access
bronze
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.